Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

PH284 is an experimental nasal spray being studied as a potential treatment for appetite loss related to serious illnesses like cancer or heart disease, according to the release. It works differently ...

She primarily reports on U.S. politics and current affairs ... for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been ...

Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) shares fell 7.6% on Friday . The stock traded as low as $0.58 and last traded at $0.67. 500 shares were traded during trading, a decline ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.